Current research on opioid receptor function
Y Feng, X He, Y Yang, D Chao… - Current drug …, 2012 - ingentaconnect.com
The use of opioid analgesics has a long history in clinical settings, although the
comprehensive action of opioid receptors is still less understood. Nonetheless, recent …
comprehensive action of opioid receptors is still less understood. Nonetheless, recent …
[PDF][PDF] Opioids and neuropathic pain
HS Smith - Pain physician, 2012 - painphysicianjournal.com
Opioids are broad spectrum analgesics that may be beneficial to alleviate the intense
perception of algesia in patients suffering with pain. They have been one of the most …
perception of algesia in patients suffering with pain. They have been one of the most …
Novel endomorphin analogs are more potent and longer-lasting analgesics in neuropathic, inflammatory, postoperative, and visceral pain relative to morphine
AK Feehan, J Morgenweck, X Zhang… - The Journal of …, 2017 - Elsevier
Activation of the mu-opioid receptor provides the gold standard for pain relief, but most
opioids used clinically have adverse effects that have contributed to an epidemic of …
opioids used clinically have adverse effects that have contributed to an epidemic of …
[HTML][HTML] Focus: Drug Development: Novel Molecular Strategies and Targets for Opioid Drug Discovery for the Treatment of Chronic Pain
Opioid drugs like morphine and fentanyl are the gold standard for treating moderate to
severe acute and chronic pain. However, opioid drug use can be limited by serious side …
severe acute and chronic pain. However, opioid drug use can be limited by serious side …
Multifunctional opioid-derived hybrids in neuropathic pain: Preclinical evidence, ideas and challenges
J Starnowska-Sokół, B Przewłocka - Molecules, 2020 - mdpi.com
When the first-and second-line therapeutics used to treat neuropathic pain (NP) fail to
induce efficient analgesia—which is estimated to relate to more than half of the patients …
induce efficient analgesia—which is estimated to relate to more than half of the patients …
Novel pharmacological nonopioid therapies in chronic pain
AD Kaye, EM Cornett, B Hart, S Patil, A Pham… - Current pain and …, 2018 - Springer
Abstract Purpose of Review Opioid use and abuse has led to a worldwide opioid epidemic.
And while opioids are clinically useful when appropriately indicated, they are associated …
And while opioids are clinically useful when appropriately indicated, they are associated …
The design of multitarget ligands for chronic and neuropathic pain
Background: Monodrug therapy has been used with success to fight various pathologies.
When one medicine fails, co-administration of two or more drugs at the same time may be …
When one medicine fails, co-administration of two or more drugs at the same time may be …
[HTML][HTML] Novel hybrid compounds, opioid agonist+ melanocortin 4 receptor antagonist, as efficient analgesics in mouse chronic constriction injury model of …
J Starnowska-Sokół, A Piotrowska, J Bogacka… - …, 2020 - Elsevier
When the nerve tissue is injured, endogenous agonist of melanocortin type 4 (MC4)
receptor, α-MSH, exerts tonic pronociceptive action in the central nervous system …
receptor, α-MSH, exerts tonic pronociceptive action in the central nervous system …
Endogenous opiates and behavior: 2011
RJ Bodnar - Peptides, 2012 - Elsevier
This paper is the thirty-fourth consecutive installment of the annual review of research
concerning the endogenous opioid system. It summarizes papers published during 2011 …
concerning the endogenous opioid system. It summarizes papers published during 2011 …
Design, Synthesis and Biological Evaluation of Two Opioid Agonist and Cav2.2 Blocker Multitarget Ligands
A Mollica, R Costante, E Novellino… - Chemical biology & …, 2015 - Wiley Online Library
N‐type voltage‐dependent Ca2+ channels (CaV2. 2) are located at nerve endings in the
central and peripheral nervous systems and are strongly associated with the pathological …
central and peripheral nervous systems and are strongly associated with the pathological …